News

You are here

Home » News

Novosanis brings Colli-Pee UAS FV-5040 with CE mark to the market offering a solution for oncology screening

16/12/2022
Novosanis has received a CE-mark for their Colli-Pee ® with special preservative solution for oncology research applications.
Read more

Collaborate with us in the fight against the spread of monkeypox

19/08/2022
The monkeypox (MPX) outbreak is an evolving global health threat. WHO and the Biden administration have declared the outbreak a global health emergency and public health emergency ,...
Read more
Novosanis launches Colli-Pee containing UAS Large Volumes offering a new solution for oncology research

Novosanis launches Colli-Pee® containing UAS Large Volumes, offering a new solution for oncology research

21/12/2021
Today, Novosanis has launched its novel solution for oncology research applications. Together with our sister company DNA Genotek, we have developed a novel stabilization chemistry, UAS TM...
Read more

Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine

10/05/2021
It is well-established that Human Papillomavirus (HPV), the primary cause of cervical cancer can be detected in first-void urine. The study by Laura Téblick (University of Antwerp, Belgium...
Read more

New podcast: Urine the 'golden sample' - Why is urine so exciting in cervical cancer prevention?

26/04/2021
We recently had the opportunity to interview Dr. Severien Van Keer, a post-doc researcher at the VAXINFECTIO research group, at the University of Antwerp.
Read more
CE-IVD marked

Colli-Pee Small Volumes Products CE Marked

31/07/2020
Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.
Read more
IUSTI2018

Home-based urine sampling for STIs

12/07/2018
Novosanis attended IUSTI2018 from June 26 to June 30 in Dublin, Ireland. Our Colli-Pee device suited for first-void urine collection allowing for improved detection of STIs was on display...
Read more
Colli-Pee

Novosanis’ medical device Colli-Pee™ US FDA listed

15/11/2016
Colli-Pee US FDA listed
Read more

Novosanis supports Urology week - Prostate Cancer detection

29/09/2016
Prostate cancer is the most common male cancer, with around 400,000 new cases every year in Europe.
Read more

Novosanis supports Urology Week Day#2

27/09/2016
For a healthy life
Read more

Novosanis supports Urology Week

26/09/2016
Urology week is an initiative from the European Association for Urology (EAU) that tries to raise awareness for urological care and its importance in improving quality of life.
Read more

When reality hits you hard-listen to Lady Ganga's story.

21/06/2016
This is the story of Michele Baldwin, a 45-year-old mother of three who was diagnosed with late-stage cervical cancer.
Read more

Pages